Market Report: Taking Stock
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Cortecs International, the biotech group, should move its domicile from Australia to Britain by late November. The switch should help the shares. They have suffered because some domestic funds are not allowed to invest in overseas stocks. Indeed, Cortecs was hit by sudden selling by a fund which acquired the shares in the mistaken belief Cortecs was British registered. The move to PLC status may also make the shares eligible for PEPs. The price firmed 2p to 175.5p.
Vocalis, a voice recognition group, recorded a 12p gain to 69.5p following a pounds 3m contract with Ericsson. It is its fourth deal with the Swedish group. The shares arrived last year at 95p and went to 123p but, before the Ericsson deal, were around their low point.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments